This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Impact of age on efficacy and toxicity of nilotinib in patients with chronic myeloid leukemia in chronic phase: ENEST1st subanalysis
Journal of Cancer Research and Clinical Oncology Open Access 31 March 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Hehlmann R, Hochhaus A, Baccarani M . Chronic myeloid leukaemia. Lancet 2007; 370: 342–350.
McNally RJ, Rowland D, Roman E, Cartwright RA . Age and sex distributions of hematological malignancies in the U. K. Hematol Oncol 1997; 15: 173–189.
Krebsregister Saarland, Germany. http://www.krebsregister.saarland.de.
Swedish Cancer Registry. 1998–2006, Annual report publications of the Centre of Epidemiology at the National Board of Health and Welfare. http://www.socialstyrelsen.se/Statistik/statistik_amne/Cancer.
Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ et al. SEER Cancer Statistics Review, 1975–2005. U.S. National Cancer Institute: Bethesda. http://www.seer.cancer.gov/csr/1975_2005/.
Harrison SJ, Johnson PRE, Holyoake TL . The Scotland Leukaemia Registry audit of incidence, diagnosis and clinical management of new patients with chronic myeloid leukaemia in 1999 and 2000. Scott Med J 2004; 49: 87–90.
Berger U, Maywald O, Pfirrmann M, Lahaye T, Hochhaus A, Reiter A et al. Gender aspects in chronic myeloid leukemia: long-term results from randomized studies. Leukemia 2005; 19: 984–989.
Ridell B, Carneskog J, Wedel H, Vilen L, Hogh Dufva I, Mellqvist UH et al. Incidence of chronic myeloproliferative disorders in the city of Göteborg Sweden 1983–1992. Eur J Haematol 2000; 65: 267–271.
Hasford J, Baccarani M, Hehlmann R, Ansari H, Tura S, Zuffa E. Interferon-alpha and hydroxyurea in early chronic myeloid leukemia: a comparative analysis of the Italian German chronic myeloid leukemia trials with interferon-a. Blood 1996; 88: 5384–5391.
Acknowledgements
This study was supported by the German José-Carreras-Leukämie-Stiftung e.V. (DJCLS-R5) and by the Bundesministerium für Bildung und Forschung, Germany, via the Competence Network ‘Akute und chronische Leukämien’ and sponsored by the Bundesministerium für Bildung und Forschung, Germany.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rohrbacher, M., Berger, U., Hochhaus, A. et al. Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany. Leukemia 23, 602–604 (2009). https://doi.org/10.1038/leu.2008.245
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2008.245
This article is cited by
-
Primary therapy and relative survival among elderly patients with chronic myeloid leukemia: a population-based study in the Netherlands, 1989–2017
Leukemia (2020)
-
Pattern of Use and Long-Term Safety of Tyrosine Kinase Inhibitors: A Decade of Real-World Management of Chronic Myeloid Leukemia
Clinical Drug Investigation (2018)
-
Impact of age on efficacy and toxicity of nilotinib in patients with chronic myeloid leukemia in chronic phase: ENEST1st subanalysis
Journal of Cancer Research and Clinical Oncology (2017)
-
The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemia
Annals of Hematology (2016)
-
Management of Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Accelerated or Blastic Phase
Drugs & Aging (2016)